Don't want ads? Subscribe or login now.

Amedisys Pays $44M To End Investors' Medicare Fraud Suit

By Cara Mannion · June 16, 2017, 7:38 PM EDT

Amedisys Inc. has agreed to pay $43.75 million to settle a shareholder suit alleging the health care provider and its top executives hid a Medicare fraud scheme that caused its stock...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Bach et al v. Amedisys, Inc. et al

Case Number

3:10-cv-00395

Court

Louisiana Middle

Nature of Suit

Securities/Commodities

Date Filed

June 10, 2010

Recent Articles By Cara

May 23, 2017
$30M Rx Service Investor Double-Crossed, Suit Says
March 22, 2017
Ex-Pot Dispenser Exec Pays SEC $12M Over Fraudulent Sales
March 14, 2017
Wells Fargo Yielded Verdict's Preclusion Of Fiduciary Claims
February 24, 2017
Cynosure Investors Sue To Block $1.4B Hologic Merger
February 03, 2017
Greenberg Traurig Settles Clawback Suit Over $2.2M In Fees
December 09, 2016
Express Scripts Says Stockholder Suit Lacks Fraud Proof
December 07, 2016
Man Who Posed As Gov't Official Gets 5 Years For $26M Fraud
November 14, 2016
Diplomat Pharmacy Faces Shareholder Suit Over Value Drop
August 19, 2016
Sheppard Mullin Adds Crowell & Moring Gov't Contracts Pro